2018 annual financial data
Atossa Therapeutics 2018 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -11,434,233 USD and net income was -11,404,934 USD.
Operating cash flow was -8,961,621 USD.
Get free Atossa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -11,434,233 USD
- Net income
- -11,404,934 USD
- Operating cash flow
- -8,961,621 USD